|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan
2 Faculty of Bioscience, Mie University, Tsu-shi, Mie 514-8507, Japan
3 Yokohama Research Centre, Chisso Corporation, Kanazawa-ku, Yokohama 236-8605, Japan
4 The Photoprotein Laboratory, Falmouth, Massachusetts 02540, USA
Reprint requests to: Atsushi Nakagawa, Institute for Protein Research, Osaka University, 32 Yamadaoka, Suita, Osaka 565-0871, Japan; e-mail: atsushi{at}protein.osaka-u.ac.jp; fax: +81-6-6879-4313.
(RECEIVED August 26, 2004; FINAL REVISION November 3, 2004; ACCEPTED November 3, 2004)
| Abstract |
|---|
|
|
|---|
Keywords: active sites; conformational changes; radiation damage; crystallography; photoprotein; EF-hand; Ca2+-binding protein; bioluminescence
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.041067805.
| Introduction |
|---|
|
|
|---|
max 465 nm) by an intramolecular reaction, decomposing into apoaequorin, coelenteramide, and CO2 (Shimomura and Johnson 1973, 1975). Apoaequorin can be regenerated into aequorin by treatment with coelenterazine and oxygen in the absence of Ca2+; in the presence of Ca2+, apoaequorin catalyzes the luminescent oxidation of coelenterazine resulting in a dim, continuous glow (Shimomura and Johnson 1975). Recently, the crystal structure of native aequorin (PDB ID: 1EJ3 [PDB] ) was determined at 2.4 Å resolution (Head et al. 2000). According to the report, the crystallographic asymmetric unit of the crystals consists of two aequorin molecules, and each molecule of aequorin contains four helix-loop-helix "EF-hand" motifs, of which three of them (EF-hands I, III, and IV) can bind Ca2+ (Head et al. 2000). Luminometric titration of aequorins with Ca2+ showed that two Ca2+ ions are needed to trigger the luminescence reaction, and the affinity of aequorin for these first two Ca2+ ions is about 20 times higher than that for the third Ca2+ ion (Shimomura 1995; Shimomura and Inouye 1996). The coelenterazine and molecular oxygen in the binding pocket of aequorin exist in their bound form, a hydroperoxide, and the terminal oxygen atom of the hydroperoxide group is stabilized by a hydrogen bonding network involving the phenolic OH of Tyr184 (Head et al. 2000). It has been suggested that the light-emitting reaction starts when the binding of Ca2+ disrupts those interactions (Head et al. 2000).
Coelenterazine, an imidazopyrazinone (7H-imidazo[1,2-
] pyrazin-3-one), is widely distributed in bioluminescent marine organisms as a luciferin (substrate for luciferase) or as a component of various Ca2+-sensitive photoproteins, such as aequorin and obelin (Shimomura et al. 1980; Thomson et al. 1997). In an effort to improve the light-emitting properties of aequorin, semi-synthetic aequorins were produced by replacing the coelenterazine moiety in aequorin with various analogues of coelenterazine (Shimomura et al. 1988, 1989, 1990, 1993a,b). The semi-synthetic aequorins obtained with the analogues containing a 2- or 8-substituent showed widely different Ca2+-sensitivities and light-emitting characteristics. On the other hand, the p-hydroxyphenyl group at the 6-position of coelenterazine appears to be required in its intact form for the formation of aequorins, and the analogues modified at this position did not form semi-synthetic aequorins with appreciable luminescence activity. To elucidate the mechanisms underlying the luminescence characteristics of semi-synthetic aequorins, we determined the atomic structures of four semi-synthetic aequorins, cp-, br-, i-, and n-aequorins, that contain a 2- or 8-substituent in their coelenterazine moiety.
In this paper, we used the previous sequence-numbering system (Head et al. 2000) to avoid confusion, and ordinary recombinant aequorin is called "native aequorin" to differentiate it from recombinant semi-synthetic aequorin.
| Results and Discussion |
|---|
|
|
|---|
-naphthylmethyl group, respectively, substituted at the C-2 position of the coelenterazine (Shimomura et al. 1993b).
|
|
Among all the structures examined, no significant difference was observed in the conformations of the amino acid residues in the binding pocket, or in the position of the coelenterazine moiety (Fig. 2A
). The superposition of the molecules A of native, cp-, i-, and br-aequorins onto the molecule A of n-aequorin (data1) gave root mean square (r.m.s.) deviations of only 0.7 Å, 0.3 Å, 0.4 Å, and 0.2 Å, respectively, considering all atoms. This result is unexpected considering the remarkable differences in the Ca2+ sensitivities of these aequorins, as well as the distinct differences in the chemical structures of the coelenterazine analogues involved. However, some significant differences were found in the interactions between the coelenterazine analogues and the amino acid residues in the binding pockets, as described below.
The structure of peroxide group bound to coelenterazine moiety
Recently, the structures of aequorin (Head et al. 2000), obelin (PDB ID: 1EL4
[PDB]
; Liu et al. 2000), obelin bound to Ca2+ (PDB ID: 1QV1
[PDB]
; Liu et al. 2003), and the W92F obelin mutant (PDB ID: 1JF2
[PDB]
; Deng et al. 2001) were solved at resolutions of 2.3 Å, 1.1 Å, 1.7 Å, and 1.72 Å, respectively. In the structure of native aequorin, it was shown that a peroxide group (OO) was attached to the C2 atom of the coelenterazine moiety, although the electron density of the terminal oxygen of the peroxide was weak (Head et al. 2000). Similar investigations on the obelin structure have provided conflicting results; the C2 atom was found to be in a mono-oxide form in one study (Liu et al. 2000), whereas the same C2 atom was reported to be peroxidized when the W92F obelin structure was solved (Deng et al. 2001). According to another report (Liu et al. 2003), obelin partially bound to Ca2+ exhibited a clear electron density for the second oxygen atom of the peroxide group. The report claimed that the binding of Ca2+ increased the structural rigidity of obelin, consequently decreasing the mobility of the O atom (Liu et al. 2003). In the present study, the electron density corresponding to the C2 peroxide group widely varied in each semi-synthetic aequorin. With cp-aequorin, the terminal oxygen of the peroxide was completely missing in the electron density map. With i- and br-aequorins, the terminal oxygen was shown only as weak density. Only n-aequorin gave an electron density map that clearly shows the terminal oxygen.
In the previous paper on the structure of native aequorin (Head et al. 2000), a crystal that had been irradiated with X rays retained about half of the peroxide in the intact form, as judged from the electron density. The irradiated crystal emitted <50% of the light emitted by the crystal before irradiation, thus implying a correlation between the damage of peroxide and the loss of luminescence activity, both caused by X-ray irradiation. In the present study, we confirmed that X-ray irradiation causes the decrease in electron density of the terminal oxygen atom using n-aequorin. n-Aequorin was more favorable for crystallography than other semi-synthetic aequorins; its crystals grew to larger sizes and gave higher resolutions with good reproducibility. We collected the reflection data sets with different exposure times. The structures were refined using the C2 mono-oxide form of n-coelenterazine as a model. In the 1-sec structure, the peak of
A-weighted mFo-DFc map clearly showed the electron density that corresponds to the terminal oxygen at the 2.0
level. Furthermore, the height of this peak varied with the exposure time (Fig. 3
). The same phenomenon was observed for i- and br-aequorins (data not shown). The radiation damage depended on the volume of the crystal, the intensity of X ray, and exposure time. The height of the electron density of the terminal oxygen varied each time depending on the crystal used, even with the same semi-synthetic aequorin and with the same exposure time. These results indicate the partial elimination of the terminal oxygen of the peroxide by X-ray irradiation. The discrepancy concerning the peroxide group in the obelin structure (Liu et al. 2000; Deng et al. 2001) must be caused by the ability of X-ray irradiation to break off the terminal oxygen atom of the peroxide group.
|
Relative to the structure of calmodulin, the F-helix of EF-hand IV is pushed aside by the 2-substituent of coelenterazine, and the E-helix of EF-hand IV is also detruded by the C-terminal loop that contains Tyr184 (Fig. 2C
). For these reasons, the interaction between the EF-hand loops of III and IV in aequorins would be stronger than in calmodulin, and the loop of EF-hand IV is consequently deformed. Based on these observations, it is suggested that EF-hands I and III bind Ca2+ more efficiently and strongly than EF-hand IV in the triggering step of the luminescence reaction.
C2 substitution
In the structures of i-, br-, and n-aequorins, which have low Ca2+ sensitivities, the water molecule (W1) that exists in the binding pocket of native aequorin is missing (Fig. 2A
). Apparently, the space of W1 is replaced by the bulky 2-substituent of the coelenterazine analogues. In the structures of native aequorin and cp-aequorin, W1 makes hydrogen bonds with the phenolic OH of the 2-substituent, the O
atom of Thr166, and the carbonyl oxygen of Ile105 (Fig. 2A
). The volumes occupied by the bulky 2-substituents are larger than that of the p-hydroxybenzyl group. Moreover, these bulky groups were inserted between the F-helix of EF-hand III and the E-helix of EF-hand IV. Thus, these bulky groups may hinder the conformational changes of EF-hand III that result upon the binding of Ca2+.
The main role of W1 in the molecules of native aequorin is considered to be the stabilization of coelenterazine moiety (Head et al. 2000). The hydrogen-bond network mediated by W1 would be easily broken during the rearrangement initiated by the binding of Ca2+. In the cases of cp-aequorin and native aequorin, abolishing the interactions with W1 by binding Ca2+ would allow a mobility to the p-hydroxybenzyl group, thus facilitating the breakdown reaction of the coelenterazine moiety and the rearrangement of the protein. Such a mechanism is supported by the fact that the luminescence of h-aequorin is 16 times more intense than that of native aequorin at the same concentration of Ca2+ (Shimomura et al. 1993b). In h-aequorin, the p-hydroxybenzyl group of coelenterazine moiety is substituted with a benzyl group, which does not form hydrogen bonds with a water molecule; in addition, the benzyl group makes no specific interactions with the residues in the binding pocket and it also causes less steric hindrance.
In the cases of i-, br-, and n-aequorins containing coelenterazine analogues with bulky C2-substituents, their Ca2+-sensitivities and luminescence reaction rates are significantly lower than those of native aequorin, despite the fact that the stabilizing W1 is absent, and that no hydrophobic interactions occur between the 2-benzyl structure and the side chains of the binding pocket. Thus, the lower Ca2+-sensitivity and slower reaction rate of i-, br-, and n-aequorins are probably due to the bulkiness of the 2-substituents. It is possible, however, that some interactions are formed between the aromatic group of the ligand and certain residues of the binding pocket in the course of the luminescence reaction. For example, the C2 benzyl group is close to His169; if the aromatic ring were appropriately placed and rotated, it could form a stacking interaction with the imidazole ring of His169. Prior to the light-emitting reaction, the position of the imidazole ring of His169 is fixed because its N
2 atom forms a hydrogen bond with Tyr184. The C2 aromatic ring is also fixed at the same position in all structures of aequorins. Such conserved configurations are probably the best arrangement for protecting coelenterazine in the binding pocket until the occurrence of specific interactions in the process of the light-emitting reaction. Since Trp129 is also located close to the C2 aromatic ring, it might have some influence on the luminescence mechanism of aequorin. The halogen atoms of the p-iodobenzyl and p-bromobenzyl groups tend to break the
interactions of the aromatic rings. It is possible that the lower Ca2+ sensitivities of i- and br-aequorins are caused not only by steric hindrance but also by the effect of the electronegative halogen atom on the benzyl group.
C8 substitution
In the molecule of native aequorin, the benzyl group at the C8 position of coelenterazine moiety is involved in a
interaction with Trp108 of EF-hand III and a stacking interaction with Lys 39 of EF-hand I. In the case of cp-aequorin, however, the 8-cyclopentylmethy group of the ligand does not form these two hydrophobic interactions (Fig. 2A
). Compared to native aequorin, cp-aequorin has a significantly higher Ca2+-sensitivity, and the half total time (time required to emit half its total light amount) is considerably shorter (Shimomura et al. 1993b), indicating an increase in the rate of the luminescence reaction. Similar increases in the Ca2+-sensitivity and reaction rate are also found with ch-aequorin, which contains a ligand containing 8-cyclohexylmethyl group (Shimomura et al. 1989).
The Ca2+ sensitivity and the reaction rate could be affected by the hydrophobic interactions that hinder the movement of the EF-hand helix, as well as by the steric hindrance due to the size of the 8-substituent of the ligand. Compared to the benzyl group in native aequorin, the 8-cyclopentylmethyl group of cp-aequorin is smaller, whereas the 8-cyclohexylmethyl group in ch-aequorin is about the same or slightly larger. Despite the clear difference in the size of the 8-substituents, the Ca2+-sensitivities of cp-aequorin and ch-aequorin are nearly the same, and both are significantly higher than that of native aequorin (Shimomura et al. 1989, 1993b). Based on these facts, the absence of hydrophobic interactions, rather than the size of the 8-substituent, appears to be the main factor that makes these aequorins highly responsive to the structural change triggered by the binding of Ca2+.
Ca2+ sensitivity
The comparison of the loop structures of EF-hands I, III, and IV suggests that the first two EF-hands can bind Ca2+ more easily than EF-hand IV. In addition, all residues interacting with the 8- and 2-substituents of coelenterazine exist on EF-hands I and III, except Thr166. Although each EF-hand motif can be superimposed almost perfectly for all semi-synthetic aequorins and native aequorin, their Ca2+ sensitivities are widely different.
The manner by which the coelenterazine moiety is recognized by the residues in the binding pocket appears to be almost identical in all semi-synthetic aequorins and native aequorin. Since the binding pocket is made up of the helices of the EF-hands, the structural characteristics of each EF-hand, such as the inter-helical angles and the relative positions, are also identical among all semi-synthetic aequorins and native aequorin. In coordinating the residues of the EF-hand loops to Ca2+, the E and F helices must move to the positions suitable for binding Ca2+. For this process to occur, the entire molecule must allow the movement of the EF-hands. In the molecule of aequorin, the helices of the four EF-hand motifs are attracted by hydrophobic forces to the coelenterazine moiety at the center of the molecule, together forming the active pocket. Under such a condition, almost all residues interacting with the coelenterazine moiety are those of the EF-hand helices. Therefore, the movement of the EF-hands and the associated changes of the protein, which take place upon the binding of Ca2+, must be under the influence of the pre-existing interactions between the EF-hand helices and coelenterazine moiety.
The luminescence reaction might be initiated as follows: Ca2+ binds to EF-hands I and III, thus changing the conformation of the coelenterazine-containing active site and breaking the hydrogen bond between the terminal oxygen of the peroxide of coelenterazine and Tyr184. It is possible that some interactions occur transiently between the protein and the coelenterazine moiety during the course of the rearrangement of protein structure that lead to the emission of light, although the protein structure eventually stabilizes in its Ca2+-bound form after the completion of the light-emitting reaction. From the present structures, it cannot be predicted what interactions would arise during the conformational change of the binding pocket.
Our structural study shows that altering the coelenterazine moiety of aequorin affects the various interactions involving the 2- and 8-substituents, which include the hydrophobic interaction, hydrogen-bonding interaction, and steric hindrance. In the aequorin molecule, the ability of EF-hands I and III to make a move in response to the binding of Ca2+ differs considerably depending on the structure of the coelenterazine involved; thus, semi-synthetic aequorins can show various different sensitivities to Ca2+.
| Conclusions |
|---|
|
|
|---|
interactions of the C8 group are absent; therefore, Ca2+-induced conformational changes of protein occur more easily than in the case of native aequorin. In br-, i-, and n-aequorin, the hydrogen bonding network mediated by W1 is absent but the steric hindrance of the C2-substituent impedes the relevant conformational changes. In the Ca2+-triggered luminescence reaction of aequorins, the first conformational change of protein takes place upon Ca2+ binding, followed by changes in the configuration of apoprotein, which eventually leads to the light emission. During this process, the configuration of the reaction pocket containing the coelenterazine moiety would also change, in accordance with various characteristics of the C2- and C8-substitutent groups, including their size and aromaticity.
The C2-benzyl structure of the coelenterazine moiety is essential for the generation of active aequorin, although no specific interaction was found between the benzyl structure and amino acid residues in the aequorin structures. In i- and br-aequorin, the halogen atoms repel the
interactions of the benzyl group and, being bulky, sterically hinder the conformational changes, features that perhaps underlie their lowered Ca2+ sensitivity.
There are two water molecules in the active site, W1 and W2. The present structures suggest that W1 stabilizes the C2-substituent, as found in the previous studies. The W2 molecule occupies an identical position in the structures of native aequorin and all semi-synthetic aequorins, and it might play some roles in the luminescence reaction. The amino-acid residues that recognize the imidazopyrazinone ring and the C6 substituent are also conserved, although we could not see any specific role for these residues beyond the stabilization of the coelenterazine moiety. It is possible, however, that these protein residues play certain important roles in the conformational change that follows the Ca2+-binding and also in the generation of aequorin, although the mechanisms involved would be difficult to predict from the present data.
The various types of intramolecular interactions observed in the present study are considered to be closely related to the Ca2+-sensitivities of aequorins, although they do not seem to be related to the capability of aequorin to emit light. After the first conformational change of aequorin triggered by the Ca2+-binding, the characteristics of the luminescence reaction are regulated by the specific interactions between the coelenterazine moiety and its associated protein residues. In order to develop a new aequorin with improved luminescence properties, attention should be focused on modifying these interactions, by the mutation of the protein as well as by changing the coelenterazine moiety.
| Materials and methods |
|---|
|
|
|---|
Data collection
Data were collected on a PX210 CCD detector (Oxford Instruments) at BL44XU at SPring-8. The total rotation angle range for the cp-, br-, and i-aequorin data was 180°, with a 1° rotation interval in each exposure frame and with exposure times of 5 sec, 2 sec, and 2 sec per frame, respectively. Three sets of different diffraction data were collected from n-aequorin crystals with different exposure times. The n-aequorin (data1) was collected at 1 sec per frame, with a total rotation angle range of 180°. n-Aequorin (data2) and n-aequorin (data3) were acquired in the following manner: Three data sets were collected from the same crystal with different position and exposure times (2 sec, 1 sec, and 7 sec per frame) in sequence, covering total rotational ranges of 180°, 345°, and 185°, respectively. n-Aequorin (data2) was prepared by merging using the 1 sec per frame data as the lower resolution set (43.53.0 Å) and the 2 sec per frame data as the higher resolution set (3.51.6 Å). n-Aequorin (data3) was prepared by merging the 1 sec per frame (low resolution) set with the 7 sec per frame (high resolution; 3.51.6Å) set. All data are processed by d*TREK (Pflugrath 1999). Data collection and refinement statistics for all semi-synthetic aequorins are shown in Table 1
.
|
A-weighted 2mFo-DFc map (Read 1986). The position of the terminal oxygen in the peroxide group of coelenterazine was determined using the
A-weighted mFo-DFc map (Read 1986), calculating the coelenterazine as a mono-oxide state. The geometry libraries of coelenterazine analogs were made using a monomer library sketcher in the CCP4 suite (Collaborative Computational Project Number 4 1994). The iodine in i-coelenterazine and the bromine in br-coelenterazine were refined with anisotropic temperature factors. The Ramachandran plot was calculated with PROCHECK (Laskowski et al. 1993), and the result is shown in Table 1Coordinates and structure factors have been deposited in the Protein Data Bank (http://www.pdb.org/), accession codes cp-aequorin: 1UHH, br-aequorin: 1UHJ, i-aequorin: 1UHI, and n-aequorin(data1): 1UHK.
| Footnotes |
|---|
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Collaborative Computational Project Number 4. 1994. The CCP4 Suite: Programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50: 760763.[CrossRef][Medline]
Deng, L., Vysotski, E.S., Liu, Z.J., Markova, S.V., Malikova, N.P., Lee, J., Rose, J., and Wang, B.C. 2001. Structural basis for the emission of violet bioluminescence from a W92F obelin mutant. FEBS Lett. 506: 281285.[CrossRef][Medline]
Harris, M. and Jones, T.A. 2001. MolrayA web interface between O and the POV-Ray ray tracer. Acta Crystallogr. D Biol. Crystallogr. 57: 12011203.[CrossRef][Medline]
Head, J.F., Inouye, S., Teranishi, K., and Shimomura, O. 2000. The crystal structure of the photoprotein aequorin at 2.3 Å resolution. Nature 405: 372376.[CrossRef][Medline]
Jones, T.A., Zou, J.-Y., Cowan, S.W., and Kjeldgaard, M. 1991. Improved methods for the building of protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110119.
Kabsch, W. 1976. A solution for the best rotation to relate two sets of vectors. Acta Crystallogr. A 32: 922923.[CrossRef]
Kraulis, P.J. 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24: 946950.[CrossRef]
Kuboniwa, H., Tjandra, N., Grzesiek, S., Ren, H., Klee, C.B., and Bax, A. 1995. Solution structure of calcium-free calmodulin. Nat. Struct. Biol. 2: 768776.[CrossRef][Medline]
Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J. App. Cryst. 26: 283291.[CrossRef]
Liu, Z.J., Vysotski, E.S., Chen, C.J., Rose, J.P., Lee, J., and Wang, B.C. 2000. Structure of the Ca2+-regulated photoprotein obelin at 1.7 Å resolution determined directly from its sulfur substructure. Protein Sci. 9: 20852093.[Abstract]
Liu, Z.J., Vysotski, E.S., Deng, L., Lee, J., Rose, J., and Wang, B.C. 2003. Atomic resolution structure of obelin: Soaking with calcium enhances electron density of the second oxygen atom substituted at the C2-position of coelenterazine. Biochem. Biophys. Res. Commun. 311: 433439.[CrossRef][Medline]
Merritt, E.A. and Bacon, D.J. 1997. Raster3D photorealistic molecular graphics. Method. Enzymol. 277: 505524.[Medline]
Murshudov, G.N., Vagin, A.A., and Dodson, E.J. 1997. Refinement of macro-molecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53: 240255.[CrossRef][Medline]
Pflugrath, J. 1999. The finer things in X-ray diffraction data collection. Acta Crystallogr. D Biol. Crystallogr. 55: 17181725.[CrossRef][Medline]
Read, R.J. 1986. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr. A 42: 140149.[CrossRef]
Shimomura, O. 1995. Luminescence of aequorin is triggered by the binding of two calcium ions. Biochem. Biophys. Res. Commun. 211: 359363.[CrossRef][Medline]
Shimomura, O. and Inouye, S. 1996. Titration of recombinant aequorin with calcium chloride. Biochem. Biophys. Res. Commun. 221: 7781.[CrossRef][Medline]
Shimomura, O. and Johnson, F.H. 1973. Chemical nature of light emitter in bioluminescence of aequorin. Tetrahedron Lett. 31: 29632966.
. 1975. Regeneration of the photoprotein aequorin. Nature 256: 236238.[CrossRef][Medline]
Shimomura, O., Johnson, F.H., and Saiga, Y. 1962. Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J. Cell. Comp. Physiol. 59: 223240.
Shimomura, O., Inoue, S., Johnson, F.H., and Haneda, Y. 1980. Widespread occurrence of coelenterazine in marine bioluminescence. Comp. Biochem. Physiol. 65B: 435437.
Shimomura, O., Musicki, B., and Kishi, Y. 1988. Semi-synthetic aequorin. An improved tool for the measurement of calcium ion concentration. Biochem. J. 251: 405410.[Medline]
. 1989. Semi-synthetic aequorins with improved sensitivity to Ca2+ ions. Biochem. J. 261: 913920.[Medline]
Shimomura, O., Inouye, S., Musicki, B., and Kishi, Y. 1990. Recombinant aequorin and recombinant semi-synthetic aequorins. Cellular Ca2+ ion indicators. Biochem. J. 270: 309312.[Medline]
Shimomura, O., Kishi, Y., and Inouye, S. 1993a. The relative rate of aequorin regeneration from apoaequorin and coelenterazine analogues. Biochem. J. 296 (Pt. 3): 549551.
Shimomura, O., Musicki, B., Kishi, Y., and Inouye, S. 1993b. Light-emitting properties of recombinant semi-synthetic aequorins and recombinant fluorescein-conjugated aequorin for measuring cellular calcium. Cell Calcium 14: 373378.[CrossRef][Medline]
Thomson, C., Herring, P., and Campbell, A. 1997. The widespread occurrence and tissue distribution of imidazolopyrazine luciferins. J. Biolumin. Chemilum. 12: 8791.[CrossRef]
Vagin, A. and Teplyakov, A. 1997. MOLREP: An automated program for molecular replacement. J. Appl. Cryst. 30: 10221025.[CrossRef]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Inouye Cloning, Expression, Purification and Characterization of an Isotype of Clytin, a Calcium-Binding Photoprotein from the Luminous Hydromedusa Clytia gregarium J. Biochem., May 1, 2008; 143(5): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rowe, A. Rothert, C. Logue, C.M. Ensor, S.K. Deo, and S. Daunert Spectral tuning of photoproteins by partnering site-directed mutagenesis strategies with the incorporation of chromophore analogs Protein Eng. Des. Sel., February 1, 2008; 21(2): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tricoire, K. Tsuzuki, O. Courjean, N. Gibelin, G. Bourout, J. Rossier, and B. Lambolez Calcium dependence of aequorin bioluminescence dissected by random mutagenesis PNAS, June 20, 2006; 103(25): 9500 - 9505. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ohashi, S. Inouye, T. Yamazaki, and H. Hirota NMR Analysis of the Mg2+-Binding Properties of Aequorin, a Ca2+-Binding Photoprotein J. Biochem., November 1, 2005; 138(5): 613 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuzuki, L. Tricoire, O. Courjean, N. Gibelin, J. Rossier, and B. Lambolez Thermostable Mutants of the Photoprotein Aequorin Obtained by in Vitro Evolution J. Biol. Chem., October 7, 2005; 280(40): 34324 - 34331. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |